Christian Mottet

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


33 publications

2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 |
2020
 
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update.
Vulliemoz M., Brand S., Juillerat P., Mottet C., Ben-Horin S., Michetti P., on behalf of Swiss IBDnet an official working group of the Swiss Society of Gastroenterology, 2020. Digestion, 101 Suppl 1 pp. 16-26. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18B18E0B30F9]
 
Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding.
Restellini S., Biedermann L., Hruz P., Mottet C., Moens A., Ferrante M., Schoepfer A.M., on behalf of Swiss IBDnet an official working group of the Swiss Society of Gastroenterology, 2020. Digestion, 101 Suppl 1 pp. 27-42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2C8F4FE620AC]
2019
 
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
Pittet L.F., Verolet C.M., Michetti P., Girardin M., Juillerat P., Mottet C., Maillard M.H., Siegrist C.A., Posfay-Barbe K.M., Swiss Inflammatory Bowel Disease Cohort Study Group, 2019/07. The American journal of gastroenterology, 114 (7) pp. 1130-1141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_908258A77893]
2016
 
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
Mottet C., Schoepfer A.M., Juillerat P., Cosnes J., Froehlich F., Kessler-Brondolo V., Seibold F., Rogler G., Vavricka S.R., Michetti P., 2016/11. Inflammatory bowel diseases, 22 (11) pp. 2733-2747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EDB26B951BC7]
2015
 
Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings : do practicing gastroenterologists agree with experts?
Pittet V., Maillard M.H., Lauvergeon S., Timmer M., Michetti P., Froehlich F., Burnand B., Vader J.P., Mottet C., 2015. Journal of Crohn's and Colitis, 9 (2) pp. 132-139. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C1791A1B926]
Azathioprine and 6-Mercaptopurine use in the Swiss IBD cohort : adverse effects, causes of discontinuation and risk of "flares" according to 6-TG levels
Lavrek D., Fournier N., Pittet V., Muller D., Mottet C., 2015., 10th Congress of ECCO - Crohns & Colitis Organisation : Inflammatory bowel diseases. 18-21 February 2015, Barcelona, Spain pp. S272-S272 dans Journal of Crohn's & Colitis ; vol. 9 supl. 1. Peer-reviewed.
[URN][WoS][serval:BIB_0CE49558DEF8]
 
Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study.
Multone E., Vader J.P., Mottet C., Schoepfer A., Fournier N., Burnand B., Michetti P., Pittet V., 2015. Scandinavian Journal of Gastroenterology, 50 (11) pp. 1348-1356.
[DOI][WoS][Pmid][serval:BIB_56D5C735889B]
2014
 
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis.
Maillard M.H., Bortolotti M., Vader J.P., Mottet C., Schoepfer A., Gonvers J.J., Burnand B., Froehlich F., Michetti P., Pittet V. et al., 2014. Journal of Crohn's and Colitis, 8 (8) pp. 825-834.
[DOI][WoS][Pmid][serval:BIB_2CC133909DCA]
 
Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.
Pittet V., Rogler G., Mottet C., Froehlich F., Michetti P., de Saussure P., Burnand B., Vader J.P., Swiss IBD Cohort Study Group*, 2014. Scandinavian Journal of Gastroenterology, 49 (6) pp. 662-673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0337252322D]
 
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Protic M., Seibold F., Schoepfer A., Radojicic Z., Juillerat P., Bojic D., Mwinyi J., Mottet C., Jojic N., Beglinger C. et al., 2014. Journal of Crohn's and Colitis, 8 (11) pp. 1427-1437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0EC12ECB30F2]
 
The gap between scientific evidence and clinical practice : 5-aminosalicylates are frequently used for the treatment of Crohn's disease
Schoepfer A.M., Bortolotti M., Pittet V., Mottet C., Gonvers J.J., Reich O., Fournier N., Vader J.P., Burnand B., Michetti P. et al., 2014. Alimentary Pharmacology and Therapeutics, 40 (8) pp. 930-937. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2974B53AC349]
 
Topical therapy is underused in patients with ulcerative colitis.
Seibold F., Fournier N., Beglinger C., Mottet C., Pittet V., Rogler G., Swiss IBD cohort study group, 2014. Journal of Crohn's and Colitis, 8 (1) pp. 56-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_833108ADD782]
2013
 
Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease.
Pittet V., Rogler G., Michetti P., Fournier N., Vader J.P., Schoepfer A., Mottet C., Burnand B., Froehlich F., 2013. Digestion, 87 (3) pp. 212-221.
[DOI][WoS][Pmid][serval:BIB_58E2C781D1C9]
 
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
Pittet V., Froehlich F., Maillard M.H., Mottet C., Gonvers J.J., Felley C., Vader J.P., Burnand B., Michetti P., Schoepfer A. et al., 2013. Journal of Crohn's and Colitis, 7 (10) pp. 820-826. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F53134CF6ED]
2012
 
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
Vavricka S.R., Spigaglia S.M., Rogler G., Pittet V., Michetti P., Felley C., Mottet C., Braegger C.P., Rogler D., Straumann A. et al., 2012/03. Inflammatory bowel diseases, 18 (3) pp. 496-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_226E7662DA72]
 
Better 6 months outcome for steroid refractory ulcerative colitis with infliximab rescue therapy compared to tacrolimus or cyclosporine: a Swiss IBD cohort retrospective analysis
Protic M., Schoepfer A., Frei P., Juillerat P., Mottet C., Mwinyi J., Rogler G., Vavricka S.R., Seibold F, 2012. pp. S6 dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association of the Study of the Liver and Swiss Society of Clinical Nutrition, Swiss Medical Weekly.
[serval:BIB_4C0D7ED60FA3]
 
Comparative short-term response and remission rates for tacrolimus, cyclosporine, and infliximab for steroid-refractory ulcerative colitis
Protic M., Schoepfer A., Frei P., Juillerat P., Mottet C., Mwinyi J., Rogler G., Vavricka S.R., Seibold F., 2012. pp. S358 dans DDW 2012, Digestive Disease Week, Gastroenterology.
[DOI][WoS][serval:BIB_8A42FCDC8986]
 
First explicit criteria to decide on the appropriateness of therapy of ulcerative colitis: the European EPATUC panel
Pittet V., Vader J.P., Gonvers J.J., Maillard M.H., Schoepfer A., Felley C., Mottet C., Michetti P., Froehlich F., 2012. pp. S224 dans DDW 2012, Digestive Disease Week, Gastroenterology.
[DOI][WoS][serval:BIB_35B69B077195]
 
First explicit criteria to decide on the appropriateness of therapy of ulcerative colitis: the European EPATUC panel
Pittet V., Vader J.P., Gonvers J.J., Maillard M., Schoepfer A.M., Felley C., Mottet C., Michetti P., Froehlich F., 2012. pp. S141 dans 7th Congress of ECCO, European Crohn's and Colitis Organisation, Journal of Crohn's and Colitis.
[DOI][serval:BIB_B8F0572E5EC6]
 
First explicit criteria to decide on the appropriateness of therapy of ulcerative colitis: the European Epatuc Panel.
Pittet V., Vader J.P., Gonvers J.J., Maillard M., Schoepfer A.M., Felley C., Mottet C., Michetti P., Froehlich F., 2012. pp. 13S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association of the Study of the Liver and Swiss Society of Clinical Nutrition, Swiss Medical Weekly.
[serval:BIB_BE97F22BA484]
 
First-line therapies in inflammatory bowel disease.
Girardin M., Manz M., Manser C., Biedermann L., Wanner R., Frei P., Safroneeva E., Mottet C., Rogler G., Schoepfer A.M., 2012. Digestion, 86 Suppl 1 pp. 6-10.
[DOI][WoS][Pmid][serval:BIB_550B42FD96A9]
 
Information seeking activity and adherence to therapy: Findings from the Swiss Inflammatory Bowel Disease Cohort Study
Pittet V., Rogler G., Mottet C., Vader J.P., 2012. pp. S179-S180 dans 7th Congress of ECCO, European Crohn's and Colitis Organisation, Journal of Crohn's and Colitis.
[DOI][serval:BIB_38A121DBD20B]
 
Is there a relationship between information concerns of patients and adherence to therapy?: results from the Swiss IBD Cohort Study.
Pittet Valérie, Rogler Gerhard, Mottet Christian, Froehlich Florian, Burnand Bernard, Vader John-Paul, Swiss IBD Cohort Study, 2012., Annual meeting of the Swiss Society of Gastroenterology, Swiss Society of Visceral Surgery, Swiss Association of the Study of the Liver, Swiss Society of Clinical Nutrition, Interlaken (Switzerland), September 20-21, 2012 pp. 13S dans Swiss Medical Weekly.
[serval:BIB_566F41E01B67]
 
Medical treatments and risk factors for resection surgery in Crohn's disease: results from the Swiss IBD Cohort Study
Pittet V., Rogler G., Michetti P., Fournier N., Vader J.P., Schoepfer A., Mottet C., Froehlich F., 2012. pp. S569 dans DDW 2012, Digestive Disease Week, Gastroenterology.
[DOI][WoS][serval:BIB_85B3A34D52AD]
 
Treatment of fibrostenotic and fistulizing Crohn's disease.
Schoepfer A.M., Safroneeva E., Vavricka S.R., Peyrin-Biroulet L., Mottet C., 2012. Digestion, 86 (Suppl 1) pp. 23-27. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C27B3A19C045]
2011
 
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel
Schoepfer A., Spigaglia S., Rogler G., Pittet V., Michetti P., Felley C., Mottet C., Braegger C., Rogler D., Straumann A. et al., 2011. pp. P345 dans 6th Congress of the European Crohn's and Colitis Organisation, Journal of Crohn's and Colitis. Peer-reviewed.
[serval:BIB_261ABBD9DE85]
 
Topische Therapie bei Colitis ulcerosa [Topical therapy of ulcerative colitis].
Rogler G., Beglinger C., Mottet C., Seibold F., Gross V., 2011. Praxis, 100 (23) pp. 1413-1424.
[DOI][Pmid][serval:BIB_1EB35BF6704D]
2010
 
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort.
Juillerat P., Pittet V., Mottet C., Felley C., Gonvers J.J., Vader J.P., Burnand B., Froehlich F., Wolters F.L., Stockbrügger R.W. et al., 2010. Scandinavian Journal of Gastroenterology, 45 (12) pp. 1449-1456. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_696479B25EEB]
 
Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
Pittet V., Juillerat P., Michetti P., Vader J.P., Burnand B., Rogler G., Beglinger C., Seibold F., Mottet C., Felley C. et al., 2010. Alimentary Pharmacology and Therapeutics, 32 (8) pp. 1007-1016. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80C2E92D5A35]
 
Differential effects of immunosuppressive drugs on effector and regulatory T cells.
Wyss J.C., Mottet C., Lechler R., Pascual M., Golshayan D., 2010. pp. 7S-8S dans Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_E7BDD30EC5AA]
 
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.
Juillerat P., Pittet V., Vader J.P., Burnand B., Gonvers J.J., de Saussure P., Mottet C., Seibold F., Rogler G., Sagmeister M. et al., 2010. European Journal of Gastroenterology and Hepatology, 22 (11) pp. 1352-1357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41AC89778070]
 
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.
Chowers Y., Sturm A., Sans M., Papadakis K., Gazouli M., Harbord M., Jahnel J., Mantzaris G.J., Meier J., Mottet C. et al., 2010. Journal of Crohn's and Colitis, 4 (4) pp. 367-376.
[DOI][WoS][Pmid][serval:BIB_D2408C003E03]
2008
 
Case Report: Human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008/10. Journal of Medical Virology, 80 (10) pp. 1804-1807.
[DOI][WoS][Pmid][serval:BIB_437055D50075]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University